|
Colin Broom M.D. has served as Vice President Chief Scientific Officer of ViroPharma since May 2004. From 2000 until 2003 Dr. Broom served as vice president of clinical development and medical affairs Europe for Amgen. From 1998 to 1999 Dr. Broom served as senior vice president of global clinical development for Hoechst Marion Roussel now Aventis. From 1984 through 1998 Dr. Broom was with Glaxo and then SmithKline Beecham where he held positions of increasing seniority in clinical pharmacology in Europe before moving to the US to head global oncology and subsequently becoming Vice President of CNS/GI. Dr. Broom holds a Bachelor of Science degree in pharmacology from University College in London and a Bachelor of Medicine and Bachelor of Surgery degree from St. George's Hospital Medical School. Dr. Broom is a Member of the Royal College of Physicians and a Fellow of the Faculty of Pharmaceutical Medicine of the UK Colleges of Physicians.
| 